Thyroid hormone deficiencies during critical periods of brain development result in profound structural as well as functional abnormalities ([@B1]--[@B4]). Several studies suggest that the critical period in which thyroid hormone exerts dramatic effects on neuronal structure appears to be predominantly during early postnatal life ([@B1]). However, maternally derived thyroid hormone, transported via the placenta, is known to alter neural progenitor proliferation, differentiation, and migration within the developing embryo, which expresses thyroid hormone receptor (TR) isoforms before the onset of fetal thyroid hormone synthesis ([@B5]--[@B11]). Furthermore, thyroid hormone is known to exert effects on neuronal and glial progenitor proliferation, survival, and maturation within the adult brain ([@B12]--[@B18]). Clinical evidence indicates that early gestational deprivation of thyroid hormone, as well as adult-onset hypothyroid status, result in cognitive and functional neurological impairments, with the early onset effects associated with more severe consequences ([@B1], [@B3], [@B19]). Taken together, these studies provide evidence of a role for thyroid hormone in modulating structure and function in the mammalian brain throughout life.

Thyroid hormone effects are mediated through the transcriptional regulation of target genes via distinct TR isoforms, encoded by the TRα and TRβ genes ([@B20]). Several thyroid hormone-responsive genes, including laminin, transient axonal glycoprotein-1, reelin, neurogenic differentiation, rabconnectin 3/neurogranin, and *Dab-1*, have been implicated in mediating thyroid hormone effects on neurodevelopment ([@B21]--[@B24]). Although many thyroid hormone-responsive genes are sensitive to thyroid hormone perturbations only during critical periods, there are relatively fewer target genes that are regulated by thyroid hormone across the lifespan ([@B25]--[@B27]). Given that thyroid hormone influences neural and glial progenitors in both the developing as well as mature nervous system, we hypothesized that the expression of developmental morphogens, which retain a powerful influence on these progenitors across the lifespan, may be regulated by thyroid hormone. Sonic hedgehog (*Shh*), a major developmental morphogen, is thought to be a key regulator of neural and oligodendroglial progenitors across development and into adulthood ([@B28]--[@B31]). Shh mediates its biological effects via its membrane-associated receptors smoothened (*Smo*) and patched (Ptc, *Ptch1*), such that Shh binding to Ptc relieves the inhibitory influence of Ptc on Smo, thus activating the downstream cascade ([@B32]). Strikingly, during amphibian metamorphosis, thyroid hormone is reported to exert its metamorphic effects within the gastrointestinal system via influencing *Xenopus* hedgehog (Xhh) expression, indicating that this developmental signaling pathway can be targeted by thyroid hormone in vertebrates ([@B33]). We hypothesized that perturbations of thyroid hormone status may influence expression of *Shh*, or its receptors Ptc and *Smo*, both in the embryonic and adult mammalian brain. Here, we provide novel evidence that perturbations of maternal and adult thyroid hormone status results in a robust and bidirectional regulation of the expression of the Shh signaling cascade in the embryonic and adult rodent brain, respectively, suggesting that this pathway may mediate some of the important neurodevelopmental effects of thyroid hormone perturbations.

Materials and Methods
=====================

Animal treatment paradigms
--------------------------

Sprague Dawley rats (220--270 g) bred in our animal-breeding colony were used for all experiments. Animals were group housed and maintained on a 12-h light, 12-h dark cycle with access to food and water *ad libitum*. All animal procedures were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Tata Institute of Fundamental Research and Columbia University Institutional Animal Ethics Committees. Shh^+/LacZ^ mice were generated by A. Kottmann through the targeting of an internal ribosome entry site LacZ construct into the 3′ untranslated region of the *Shh* gene keeping the *Shh* coding sequence intact ([@B34], [@B35]).

To address the influence of maternal hypothyroidism on the Shh signaling cascade in the embryo, female rats were subjected to sham surgery or thyroidectomized (n = 4--5 dams per group) and allowed recovery for a week. Thyroidectomized and control dams were set up for mating with the day of vaginal plug being considered as d 0.5. After detection of a vaginal plug, 6-*n*-propyl-2-thiouracil (PTU) (0.05%; Sigma, St. Louis, MO) was added to the drinking water of thyroidectomized dams till sacrifice. Embryos were harvested from hypothyroid and control animals at embryonic d (e)13.5 (n = 11--15 embryos per group). All embryos used in these studies were age matched. Embryos harvested from hypothyroid dams showed decreased body size, and to rule out differences due to a possible developmental lag, all embryos used in the study were also somite matched. To address the influence of maternal hyperthyroidism, pregnant dams received T~3~ (1 mg/kg) or vehicle (0.02 [n]{.smallcaps} NaOH) injections ip from the day the vaginal plug was observed until killing at e13.5 (n = 7 embryos per group derived from three to four dams per group). After decapitation, the embryonic head was frozen on dry ice and stored at −70 C.

To address the influence of adult-onset hypothyroidism on Shh pathway expression, male rats received the goitrogens 2-mercapto-1-methylimidazole (MMI) (Sigma) or PTU (n = 4/group). MMI (0.025%) or PTU (0.05%) in drinking water for a period of 28 and 21 d, respectively, whereas controls received normal drinking water. To address the influence of adult-onset hyperthyroidism, T~3~ (0.5 mg/kg) or vehicle (0.02 [n]{.smallcaps} NaOH) was sc administered daily for 10 d with animals killed 2 h after the last T~3~ injection (n = 5--6/group). To address the influence of acute T~3~ treatment, adult male rats received a single sc injection of T~3~ (0.5 mg/kg) or vehicle (0.02 [n]{.smallcaps} NaOH) and were killed 3 h later \[n = 3--5/group for *in situ* hybridization and n = 7--10/group for chromatin immunoprecipitation (ChIP)\]. All animals were killed via rapid decapitation, and brains were fresh frozen on dry ice and stored at −70 C until use.

To examine the influence of short-duration thyroid hormone treatment, Shh^+/LacZ^ reporter mice were injected sc twice daily with T~3~ (0.5 mg/kg) or vehicle (0.02 [n]{.smallcaps} NaOH) for 2 d and killed 2 d after the last T~3~ injection (n = 5/group) via transcardial perfusion. The brains were postfixed in 4% paraformaldehyde and free-floating sections (30 μ[m]{.smallcaps}) obtained using a vibratome (TPI, St. Louis, MO).

Trunk blood was collected from all animals at the time of killing and serum T~3~ levels determined using the commercially available RIA kit (RIAK-4/4A; BRIT, Mumbai, India) as previously described ([@B36]). Serum T~3~ levels are shown in Supplemental Table 1, published on The Endocrine Society\'s Journals Online web site at <http://endo.endojournals.org>.

Primary cortical cultures
-------------------------

Cortical neurons were isolated from rat embryos (e17.5). After removal of meninges, the cleaned cortices were placed in trypsin-EDTA (Invitrogen, Carlsbad, CA) for 15 min followed by washes with cold HEPES buffered Hank\'s balanced salt solution (Invitrogen) and dissociated in culture medium (Neurobasal medium supplemented with 2% B27 supplement, 0.5 m[m]{.smallcaps} [l]{.smallcaps}-glutamine, 5 U/ml penicillin, and 5 U/ml streptomycin) (Invitrogen). Cells were plated on Poly-[d]{.smallcaps}-lysine (Sigma) coated 35-mm dishes at a density of 10^6^ cells/dish. Neurons were allowed to attach and extend processes for 9 d *in vitro* before initiating treatment with 20 n[m]{.smallcaps} T~3~ (Sigma) for 3 h. Cells were harvested 3 h after T~3~ treatment and processed for RNA extraction, with all assays performed in triplicate.

Quantitative PCR (qPCR)
-----------------------

RNA purification, cDNA synthesis, and qPCR were performed as described previously ([@B37]). In brief, total RNA was isolated using Tri Reagent (Sigma), according to the manufacturer\'s protocol. The RNA was quantified using Nanodrop (Eppendorf, Hamburg, Germany) and 2 μg of RNA per sample was used to prepare cDNA using the Quantitect RT kit (QIAGEN, Valencia, CA). cDNA was amplified in a Realplex mastercycler (Eppendorf) and visualized using a SYBR Green kit (Applied Biosystems, Foster City, CA). Hypoxanthine phosphoribosyl transferase (*Hprt*) was used as an endogenous housekeeping gene control. To compare the expression of *Hprt* and target genes, the comparative threshold cycle (*C*~T~) method was used as described previously ([@B38]). Δ*C*~T~ = absolute *C*~T~ value − endogenous *C*~T~ value; and ΔΔ*C*~T~ = Δ*C*~T~ T~3~ treatment − Δ*C*~T~ control. Data are fold change ± [sem]{.smallcaps} compared with control. Primer sequences used are described in Supplemental Table 2.

*In situ* hybridization
-----------------------

*In situ* hybridization was carried out as previously described ([@B39], [@B40]). Cryostat-cut sections were thaw mounted onto Probe-on plus slides (Electron Microscopy Sciences, Hatfield, PA). Slides were fixed, acetylated, and dehydrated before storage at −70 C. *Smo*, Ptc, and *Shh* cRNA probes were generated from transcription competent pGEM-4Z plasmids provided by Martial Ruat (Centre National de la Recherche Scientifique, France). Antisense cRNA probes were transcribed using ^35^S-labeled uridine-5′-triphosphate (Amersham, Buckinghamshire, UK). Slides were incubated for 18--20 h at 60 C in hybridization buffer containing ^35^S-uridine-5′-triphosphate-labeled riboprobes at a concentration of 1 × 10^6^ cpm/150 μl. Within an individual experiment, all slides were exposed to the same batch of riboprobe. After hybridization, slides were subjected to ribonuclease A (20 μg/ml) treatment, followed by stringent washes in decreasing concentrations of saline sodium citrate. Slides were air dried and exposed to Biomax film (Kodak, New York, NY) for 3 wk. All slides within a single experiment were exposed to the same film to reduce variability that may arise during autoradiographic film development. Sense riboprobes, or a ribonuclease (40 μg/ml at 37 C for 30 min) prehybridization wash, did not yield significant hybridization (data not shown), confirming the specificity of the signal observed.

Levels of *Shh*, Ptc, and *Smo* transcripts were analyzed using the Macintosh-based Scion Image software (Scion, Frederick, MD). To correct for nonlinearity, ^14^C standards were used for calibration. An equivalent area was outlined for each sample, and optical density measurements ([@B6]--[@B8]) from both sides of three to four individual sections from each animal were analyzed, from which the mean value was calculated. *Shh* mRNA expression in embryonic brain was quantitated in the ventral telecephalon (VT), zona limitans intrathalamica (Zli), and hypothalamus (Hyp). *Shh* transcript expression in the adult brain was analyzed in the vertical limb of the diagonal band (VDB), cingulate cortex, cortical layer V, medial region and lateral region of striatum, and dentate gyrus (DG) subfield of the hippocampus. *Smo* and Ptc mRNA expression was determined in the embryonic brain within the VT, Zli, Hyp, and cortex. *Smo* and Ptc mRNA expression was determined in the adult brain within the cortex, medial and lateral striatum, and subventricular zone (SVZ) lining the lateral ventricles and the DG.

Immunofluorescence
------------------

Immunofluorescence staining for β-galactosidase was performed on sections from Shh^+/LacZ^ animals. In brief, sections were incubated with primary antibody: goat anti-β-galactosidase (1:250; AbD Serotec, Kidlington, UK) for 3 d at 4 C and were then incubated with a secondary antibody: Alexa Fluor 488-conjugated antigoat (1:250; Invitrogen) for 2 h. Quantitative analysis for β-galactosidase immunopositive cells was performed by an experimenter blind to the treatment conditions, and only those cells that were strongly immunopositive were counted as β-galactosidase positive cells. Double immunofluorescence experiments for β-galactosidase with the neuronal marker neuronal nuclei (NeuN), the chondroitin sulfate proteoglycan NG2, the 2′,3′-cyclic nucleotide 3′-phosphodiesterase RIP, or the glial fibrillary acidic protein (GFAP) were carried out as previously described ([@B35]). In brief, sections were incubated with primary antibody cocktails of goat anti-β-galactosidase with mouse anti-NeuN (1:500; Millipore Corp., Bedford, MA) or mouse anti-RIP (1:10; Developmental Studies Hybridoma Bank, Iowa City, IA) along with rabbit anti-NG2 (1:250; Millipore Corp.) or rabbit anti-GFAP (1:250; Millipore Corp.). After incubation with primary antibody for 3 d at 4 C, sections were washed and incubated with a cocktail of secondary antibodies: Alexa Fluor 488-conjugated antigoat (1:250); rhodamine-conjugated antimouse IgG (1:500; Millipore Corp.), and Cy-5-conjugated antirabbit IgG (1:500; Millipore Corp.) for 2 h. Sections were mounted onto slides with Vectashield (Vector Laboratories, Burlingame, CA) and analyzed using a Zeiss Axioplan2 confocal laser scanning microscope (Zeiss, Oberkochen, Germany). Double immunofluorescence experiments on primary cortical neurons for all TR antibodies with the neuronal marker microtubule-associated protein (MAP)-2 were carried out as described above using a combination of all the TR antibodies, *i.e*. goat anti-TRα, TRβ1, and TRβ2 (1:200 each; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) along with mouse anti-MAP-2 (1:1000; Sigma). Secondary antibodies used were Alexa Fluor 488-conjugated antigoat (1:400) and rhodamine-conjugated antimouse IgG (1:500). Nuclei were counterstained using Hoechst 33342 (Invitrogen).

ChIP assay
----------

ChIP was carried out as described previously ([@B41]). Briefly, bilateral cortices were dissected, fixed to cross-link the DNA and the bound proteins. The tissue was dounce homogenized, sonicated, and immunoprecipitated using a pan-acetylation histone 3 (H3) or pan-acetylation histone 4 (H4) antibody (1 μg; Cell Signaling Technology, Beverly, MA). After reverse cross-linking and chromatin precipitation, qPCR analysis was performed within upstream regions of the *Shh* gene. Putative TR binding sites were analyzed for the 5′ upstream sequence of the rat Shh gene from −6500 to the transcriptional start site using AliBaba 2.1 (<http://www.gene-regulation.com/pub/programs.html>). Of the several putative TRα and TRβ binding sites identified, a region containing both putative TRα and TRβ binding sites was amplified, and a second region from −184 to the transcriptional start site was amplified. We also performed qPCR analysis to examine possible enrichment of acetylated histones H3 (AcH3) and H4 (AcH4) within upstream regions of the Ptc and *Smo* genes. In each sample, the results were normalized to a region amplified from the glyceraldehyde-3-phosphate dehydrogenase promoter. Primer sequences used in ChIP experiments are described in Supplemental Table 2.

Statistical analysis
--------------------

Results were subjected to statistical analysis using Student\'s unpaired *t* test for experiments with two groups and one-way ANOVA for experiments with three groups (Prism; GraphPad, San Diego, CA). When two groups compared exhibited unequal variances, statistical analysis was performed using a Student\'s unpaired *t* test with a Welch correction. Differences were considered to be statistically significant at *P* \< 0.05.

Results
=======

Maternal hypothyroidism decreases *Shh* signaling cascade expression in the embryonic rat brain
-----------------------------------------------------------------------------------------------

Shh is expressed in ventral signaling areas within the Hyp and ventral telencephalon, where it is critical for the development of the ventral forebrain, specifying cell fate choice, proliferation, and survival ([@B42]--[@B44]). Shh is also expressed within the Zli, where it regulates the development of adjacent dorsal and ventral thalamic structures ([@B45]--[@B48]). Although most studies have focused on the consequences of hypothyroidism at late embryonic and postnatal stages in the rodent brain, the fetus that expresses TRs before the onset of fetal thyroid hormone synthesis is exposed to maternal thyroid hormone transported via the placenta from the earliest stages of embryonic forebrain development. We analyzed the consequences of maternal hypothyroidism on the regulation of *Shh* mRNA and its receptors in the early embryonic brain. E13.5 embryos harvested from hypothyroid dams exhibited a significant down-regulation of *Shh* mRNA in the Zli ([Fig. 1](#F1){ref-type="fig"}B). Expression of *Shh* in the ventral telencephalon and the Hyp remained unchanged in these embryos. In addition, Ptc mRNA expression in the embryonic brain was also significantly down-regulated in the ventral telencephalon and in the Zli ([Fig. 1](#F1){ref-type="fig"}C). The Shh signaling receptor, *Smo*, displayed a down-regulation in a more wide-spread manner, in areas that are responsive to secreted Shh, including the entire thalamus, the ventral telencephalon, and the developing embryonic neocortex ([Fig. 1](#F1){ref-type="fig"}D). Our results indicate that maternal hypothyroidism significantly decreases expression of *Shh* and its coreceptors Ptc and *Smo* in the embryonic rodent brain.

![Maternal hypothyroidism decreases Shh signaling cascade expression in the embryonic rat brain. Rat e13.5 pups were obtained from thyroidectomized females that were administered PTU (Tx + PTU), and levels of *Shh*, Ptc, and *Smo* mRNA were determined by *in situ* hybridization. Shown is a schematic representation of a coronal section through the embryonic rat brain with a *color code* depicting the regions quantitated (A) and representative autoradiographs of *Shh* (B), Ptc (C), and *Smo* (D) mRNA in embryos derived from control and hypothyroid (Tx + PTU) female dams. Maternal hypothyroidism resulted in a significant decrease in *Shh* mRNA in the Zli with no change in the VT or Hyp (B). Ptc and *Smo* mRNA were significantly down-regulated in several forebrain regions (namely the VT, Zli, Lat.Ctx and Med.Ctx) of e13.5 embryos derived from hypothyroid dams (C and D). Results are expressed as a percentage of control and are the mean ± [sem]{.smallcaps} (n = 11--15 embryos per group derived from four to five dams in each group). \*, *P* \< 0.05 compared with embryos derived from control dams (Student\'s unpaired *t* test). *White bars*, Embryos derived from vehicle-treated dams; *black bars*, embryos derived from Tx + PTU-treated dams.](zee0051159020001){#F1}

Maternal hyperthyroidism enhances the expression of *Shh* in the embryonic rat brain
------------------------------------------------------------------------------------

In contrast to the decreased *Shh* ligand expression in embryos derived from hypothyroid dams, an opposite effect was seen in embryos obtained from hyperthyroid dams. These embryos exhibited a significant up-regulation in *Shh* mRNA levels in the major signaling centers of the ventral telencephalon, Zli, and in the hypothalamic region ([Fig. 2](#F2){ref-type="fig"}A). However, we did not observe any change in the expression of the Shh receptors, Ptc and *Smo* ([Fig. 2](#F2){ref-type="fig"}, B and C). Our results indicate that Shh signaling from embryonic ventral forebrain signaling centers is likely to be enhanced with maternal hyperthyroidism due to a robust up-regulation of the ligand.

![Maternal hyperthyroidism enhances the expression of *Shh* in the embryonic rat brain. Rat e13.5 pups were derived from vehicle-treated and chronic T~3~-treated dams, and the levels of *Shh*, Ptc, and *Smo* mRNA were determined by *in situ* hybridization. Shown are representative autoradiographs showing *Shh* mRNA expression (A) in the VT, Zli, and Hyp in e13.5 embryos derived from vehicle or T~3~-treated dams. Maternal hyperthyroidism resulted in a significant induction in *Shh* mRNA in the VT, Zli, as well as Hyp, of the embryonic brain (A). Ptc and *Smo* mRNA remained unaltered in embryos derived from maternally hyperthyroid dams (B and C). Results are expressed as a percentage of control and are the mean ± [sem]{.smallcaps} (n = 7/group derived from three to four dams in each group). \*, *P* \< 0.05 when compared with control (Student\'s unpaired *t* test). *White bars*, embryos derived from vehicle-treated dams; *black bars*, embryos derived from chronic T~3~-treated dams.](zee0051159020002){#F2}

Adult-onset hypothyroid status selectively decreases *Smo* mRNA in the DG subfield of the hippocampus
-----------------------------------------------------------------------------------------------------

*Shh* continues to be expressed within specific regions in the adult mammalian brain, including the neocortex, striatum, and the VDB ([@B49]). Although Ptc expression is widespread in the adult brain, the signaling coreceptor *Smo* is predominantly expressed in the adult neurogenic niches, namely the SVZ lining the lateral ventricles and in the DG subfield of the hippocampus ([@B49]). Adult hypothyroid status resulted in no change in the expression of *Shh* mRNA (Supplemental Fig. 1). The expression of Ptc mRNA as well remained unaltered in adult hypothyroid animals (Supplemental Fig. 1). In contrast, adult-onset hypothyroidism significantly down-regulated the expression of the signaling receptor *Smo* in the DG ([Fig. 3](#F3){ref-type="fig"}B). Interestingly, hypothyroid animals did not show any change in *Smo* expression within the other major neurogenic niche of the SVZ ([Fig. 3](#F3){ref-type="fig"}B).

![Adult-onset hypothyroidism decreases *Smo* mRNA expression in the DG subfield of the hippocampus. Adult male rats were rendered hypothyroid by administration of MMI for 28 d, or PTU for 21 d, and the levels of *Smo* mRNA were determined by *in situ* hybridization. Shown are schematic representations of coronal sections through the ventricular zone and hippocampus of the adult rodent brain highlighting the SVZ and the DG region of the hippocampus, respectively (A). *Smo* mRNA was significantly and selectively down-regulated in the DG after adult-onset hypothyroidism compared with vehicle-treated controls (B). Results are expressed as a percentage of control and are the mean ± [sem]{.smallcaps} (n = 4/group). \*, *P* \< 0.05 compared with control (one-way ANOVA, Bonferroni *post hoc* test). *White bars*, Vehicle-treated controls; *gray bars*, MMI-treated animals; *black bars*, PTU-treated animals.](zee0051159020003){#F3}

*Shh* mRNA is significantly up-regulated in the adult rat brain in response to chronic T~3~ administration
----------------------------------------------------------------------------------------------------------

Chronic T~3~ administration in adulthood resulted in a significant up-regulation of *Shh* mRNA in several brain regions, including the cortex, VDB, and lateral striatum ([Fig. 4](#F4){ref-type="fig"}, B and C). Further, Ptc mRNA expression was also significantly up-regulated in several regions of the adult rodent brain ([Fig. 4](#F4){ref-type="fig"}, B and D). In addition, mRNA expression of the Shh signaling receptor *Smo* was also increased in the DG ([Fig. 4](#F4){ref-type="fig"}, B and E). Strikingly, *Smo* expression was also robustly enhanced in superficial layers of neocortex in hyperthyroid brains, whereas *Smo* mRNA signal was almost undetectable in euthyroid controls using *in situ* hybridization ([Fig. 4](#F4){ref-type="fig"}, B and E).

![*Shh* mRNA is significantly up-regulated in the adult rat brain in response to chronic T~3~ administration. Adult male rats received chronic T~3~ (Chr T~3~) administration for a period of 10 d to render them hyperthyroid, and the levels of *Shh*, Ptc, and *Smo* mRNA were determined by *in situ* hybridization. Shown is a schematic representation of a coronal section of the adult rat brain with a *color code* depicting the regions quantitated (A). Also shown are representative autoradiographs of *Shh*, Ptc, and *Smo* mRNA expression in coronal sections of the adult brains from vehicle and chronic T~3~-treated male rats (B). Adult-onset hyperthyroidism resulted in a robust and significant increase in *Shh* expression in the VDB, cortex, and Lat.St (C). Chronic T~3~ treatment significantly increased the expression of Ptc (D) and *Smo* (E) mRNA in the adult rat brain. Results are expressed as a percentage of control and are the mean ± [sem]{.smallcaps} (n = 5--6/group). \*, *P* \< 0.05 compared with control (Student\'s unpaired *t* test). *White bars*, Vehicle-treated controls; *hatched bars*, chronic T~3~-treated animals.](zee0051159020004){#F4}

Subchronic T~3~ administration enhances neocortical β-galactosidase positive cell numbers in *Shh*^+/LacZ^ mice
---------------------------------------------------------------------------------------------------------------

Short-duration T~3~ treatment in *Shh*^+/LacZ^ mice resulted in a significant increase in the number of β-galactosidase immunopositive cells within the neocortex ([Fig. 5](#F5){ref-type="fig"}A). These results are consistent with the hypothesis that *Shh* is a thyroid hormone-responsive gene in the adult mammalian brain. To gain an understanding of the cell types that express Shh within the neocortex ([Fig. 5](#F5){ref-type="fig"}B), we performed double labeling experiments for β-galactosidase with neuronal and glial markers. Cells expressing β-galactosidase colocalized with the neuronal marker NeuN ([Fig. 5](#F5){ref-type="fig"}C), indicating presence of the reporter in cortical neurons. We did not observe any β-galactosidase expression within oligodendroglial cells expressing NG2 or RIP or in GFAP-immunopositive astrocytes ([Fig. 5](#F5){ref-type="fig"}C).

![Subchronic T~3~ treatment enhances the number of β-galactosidase immunopositive cells within the neocortex of *Shh*^+/LacZ^ mice. Shown are representative images of β-galactosidase expressing cells in the cortex after short-duration T~3~ treatment over 2 d in *Shh*^+/LacZ^ mice. T~3~ treatment significantly increased the number of cells that were strongly immunopositive for β-galactosidase in layer V of cortex (A). Results are expressed as a percentage of vehicle-treated control and are the mean ± [sem]{.smallcaps} (n = 5/group). \*, *P* \< 0.05 compared with control (Student\'s unpaired *t* test). Shown is a schematic representation (B) of a coronal section illustrating β-galactosidase immunopositive cells in *Shh*^+/LacZ^ mice. The *boxed area* is enlarged to show a representative area indicating the presence of several strongly immunopositive β-galactosidase immunopositive cells in the neocortex of T~3~-treated *Shh*^+/LacZ^ mice. Double immunofluorescence experiments revealed the colocalization of β-galactosidase with the mature neuronal marker NeuN but not with the astroglial (GFAP) or oligodendrocytic (RIP or NG2) markers examined (C).](zee0051159020005){#F5}

Acute T~3~ administration induces the expression of *Shh* mRNA in the adult brain and cortical neurons *in vitro*
-----------------------------------------------------------------------------------------------------------------

Next, we examined whether acute T~3~ treatment influences *Shh* expression *in vivo*. Acute T~3~ administration resulted in a significant up-regulation of *Shh* mRNA in layer V of cortex, as well as the lateral striatum of adult rats, suggesting a rapid transcriptional regulation of *Shh* mRNA by T~3~ ([Fig. 6](#F6){ref-type="fig"}A). To address direct effects of T~3~ on cortical neuronal *Shh* mRNA levels, we performed qPCR analysis on primary cortical neurons *in vitro* that were treated with 20 n[m]{.smallcaps} T~3~ for 3 h. Primary cortical cultures significantly up-regulated *Shh* mRNA in response to acute T~3~ treatment, supporting a direct effect of T~3~ on *Shh* expression ([Fig. 6](#F6){ref-type="fig"}C). Cortical neurons were found to express TRs *in vitro* as confirmed by immunohistochemistry experiments ([Fig. 6](#F6){ref-type="fig"}B).

![Acute T~3~ treatment increases Shh mRNA expression *in vivo* and *in vitro*. Adult male rats received a single injection of T~3~, and the levels of *Shh* mRNA were determined 3 h later by *in situ* hybridization. Acute T~3~ treatment resulted in a significant increase in *Shh* mRNA expression in the cortex and Lat.St (A). Results are expressed as a percentage of control and are the mean ± [sem]{.smallcaps} (n = 3--5/group). \*, *P* \< 0.05 compared with vehicle-treated controls (Student\'s unpaired *t* test). Ctx(V), Cortical layer V. *Shh*, Ptc, and *Smo* mRNA was determined by qPCR from T~3~-treated primary cortical neuron cultures, isolated from e17.5 pups that were grown *in vitro* for 9 d before acute treatment with 20 n[m]{.smallcaps} T~3~ for 3 h. Shown are representative images of MAP-2 immunopositive primary cortical neurons expressing all TR isoforms (B) with their nuclei counterstained with Hoechst 33342. Acute T~3~ treatment of cortical cultures resulted in a significant increase in *Shh* mRNA expression, whereas Ptc and *Smo* mRNA remained unchanged as revealed by qPCR analysis (C). All genes were normalized to the housekeeping gene *Hprt*. Results are expressed as fold change and are the mean ± [sem]{.smallcaps} (n = 3--5/group). \*, *P* \< 0.05 compared with vehicle-treated controls (Student\'s unpaired *t* test).](zee0051159020006){#F6}

Thyroid hormone treatment is associated with enhanced histone acetylation of the *Shh* promoter
-----------------------------------------------------------------------------------------------

To investigate whether the rapid transcriptional up-regulation of *Shh* after acute T~3~ treatment *in vivo* is associated with enhanced histone acetylation at the *Shh* promoter, we carried out ChIP assays for AcH3 and AcH4 within upstream regions of the *Shh* gene in cortical tissue. After ChIP, we performed qPCR analysis for upstream regions of the *Shh* gene that contained putative thyroid hormone response elements (TREs) (−6423 to −6413 bp and −6270 to −6261 bp) and also within the first 200 bp from the transcriptional start site. Our results revealed that neocortical tissue derived from T~3~-treated animals had significantly enhanced acetylation of both histone H3 and H4 at putative TRE-containing regions upstream of the *Shh* gene and close to the transcriptional start site in the *Shh* promoter ([Fig. 7](#F7){ref-type="fig"}, A and B).

![Acute T~3~ treatment increases histone acetylation within upstream regulatory regions of the *Shh* gene in the adult rat cortex. ChIP assays were performed for pan histone H3 and H4 acetylation changes within gene regulatory sequences from −184 bp to the transcriptional start site of the *Shh* gene. Cortical tissue derived from T~3~-treated animals had significantly enhanced acetylation of histone H3 and H4 (AcH3 and AcH4) close to the transcriptional start site within the *Shh* promoter after acute T~3~ treatment (A). ChIP analysis within upstream regions of the *Shh* gene that contained putative TREs (−6554 to −6204 bp) revealed that cortical tissue derived from T~3~-treated animals had increased acetylation of both histone H3 and H4 within these regulatory sequences as well (B). Results are expressed as fold change and are the mean ± [sem]{.smallcaps} (n = 7--10/group). \*, *P* \< 0.05 compared with vehicle-treated controls (Student\'s unpaired *t* test).](zee0051159020007){#F7}

We next examined whether acute T~3~ treatment influenced acetylation within the first 200 bp from the transcriptional start site of both the Ptc and *Smo* genes. We observed no change in the enrichment of AcH3 and AcH4 within Ptc or *Smo* gene upstream regulatory regions. AcH3 at the Ptc and *Smo* promoter, fold change (Ptc): control, 1 ± 0.39; T~3~ treated, 0.75 ± 0.44; fold change (*Smo*): control, 1 ± 0.24; T~3~ treated, 1.41 ± 0.40. AcH4 at the Ptc and *Smo* promoter, fold change (Ptc): control, 1 ± 0.34; T~3~ treated, 1.31 ± 0.52; fold change (*Smo*): control, 1 ± 0.22; T~3~ treated, 0.97 ± 0.35. Data are the mean ± [sem]{.smallcaps} (*P* \> 0.05, Student\'s *t* test). Taken together, these data indicate that the enhanced expression of *Shh* mRNA in the cortex is accompanied by significant increases in histone acetylation levels within *Shh*, but not Ptc or *Smo*, transcriptional regulatory sequences.

Discussion
==========

Thyroid hormone is known to exert profound effects on neurodevelopment and retains a powerful influence on plasticity within the mature brain, including key effects on adult hippocampal neurogenesis ([@B13], [@B15], [@B50], [@B51]). Although several thyroid hormone-responsive genes, such as reelin, *Dab-1*, and Neurogenic differentiation, have been hypothesized to mediate the neurodevelopmental influences of thyroid hormone, most of these genes are transcriptionally responsive to thyroid hormone only during select developmental time windows ([@B22], [@B52]). In contrast, there are relatively few genes that retain thyroid hormone responsivity across the life span, for example neuroendocrine specific protein and octamer transcription factor-1, which are reported to be regulated in both the embryonic and adult brain ([@B24]). Such thyroid hormone-responsive genes are particularly interesting, because they are candidates to mediate the effects of thyroid hormone in both the developing and mature brain. Although the effects of thyroid hormone are spatiotemporally specific, it is quite possible that the same sets of target genes may be redeployed across the lifespan to mediate diverse developmental and neuroplastic consequences. We provide novel evidence that the major developmental morphogen *Shh* is a thyroid hormone-responsive gene from the very earliest stages of embryonic forebrain development into adulthood.

Perhaps the most dramatic example of the tissue morphoregulatory effects of thyroid hormone are those observed during amphibian metamorphosis, a process entirely dependent on the induction of a genetic program by thyroid hormone ([@B53]). Previous evidence indicates that Xhh is an early, direct target gene of thyroid hormone and is required to mediate the metamorphic effects of thyroid hormone in the gastrointestinal system ([@B33]). It is interesting to note that thyroid hormone-mediated induction of Xhh in tadpoles is tissue-specific with no effects observed in the brain ([@B33]). In contrast, we find that in the embryonic and adult mammalian brain, thyroid hormone perturbations induce a bidirectional regulation of the *Shh* signaling cascade in a region-specific manner. Although TRs are known to be expressed in the fetal brain well before the initiation of embryonic thyroid hormone synthesis ([@B7], [@B9]), and epidemiological evidence indicates that thyroid hormone perturbations in the first trimester influence fetal brain development ([@B1], [@B54]), so far, only few thyroid hormone-responsive genes within the fetus have been identified ([@B55], [@B56]). Our results indicate that maternal hyperthyroidism significantly up-regulates embryonic *Shh* expression in ventral forebrain signaling areas and the diencephalic signaling center of the Zli, and maternal hypothyroidism results in a region-specific decline of *Shh* within the embryonic Zli. This suggests that effective Shh signaling from ventral forebrain signaling areas is likely to be enhanced with maternal hyperthyroidism due to a robust up-regulation of the ligand, and reduced with maternal hypothyroidism, due to down-regulation of the receptor complex as well as reduced ligand from the Zli.

Our results raise the possibility that specific neurodevelopmental actions of thyroid hormone may be mediated by its control of the Shh pathway, providing a mechanistic link between thyroid hormone perturbations and early developmental effects. For example, maternal thyroid hormone deficiency is associated with impaired cortical interneuron development, in particular of parvalbumin and calretinin immunoreactive neocortical interneurons ([@B10], [@B11], [@B57]). It is particularly intriguing in this regard to note that reduced Shh signaling in the embryonic ventral forebrain alters cortical interneuron composition, reducing parvalbumin positive interneuron number ([@B58]).

Adult-onset perturbations in thyroid hormone status also significantly regulated the expression of *Shh* signaling components in a bidirectional fashion, suggesting a continued sensitivity of *Shh* expression to thyroid hormone into adulthood. T~3~ administration resulted in enhanced *Shh* mRNA levels within the adult neocortex, VDB, and lateral striatum, accompanied by significant increases in the expression of both Ptc and *Smo* mRNA. Excess thyroid hormone levels also appear to unmask *Smo* expression within the neocortex, a brain region that normally has very low levels of *Smo* mRNA in euthyroid controls, and this could serve to potentiate the thyroid hormone-mediated effects on the Shh signaling pathway through increased expression of both the ligand as well as the signaling receptor. The enhanced Ptc expression observed in T~3~-treated adult animals could be interpreted as reflective of such increases in Shh signaling, because Ptc is a transcriptional target of Shh ([@B59], [@B60]). T~3~ administration also significantly enhanced *Smo* mRNA within the hippocampal neurogenic niche. It is possible that enhanced Shh ligand from the VDB may be transported via the septo-hippocampal pathway resulting in increased Shh signaling within the hippocampus ([@B61]), which is supported by the evidence of enhanced Ptc expression in the DG. In this context, it is noteworthy that T~3~ administration is capable of increasing the postmitotic survival and neuronal differentiation of hippocampal progenitors ([@B62]), an effect that overlaps with the enhanced survival observed after treatment with Smo agonists ([@B63]).

Although adult hyperthyroidism significantly enhanced *Shh* ligand expression, we did not observe any change in the ligand in adult-onset hypothyroid animals within the brain regions examined. It is possible to speculate that despite reduced circulating thyroid hormone levels, thyroid hormone availability in specific adult brain regions may not exhibit as steep a decline through the modulation of local deiodinase expression and activity. It is possible that the relative extent of unliganded TR repressor effects on *Shh* mRNA expression may still be minimal in the adult-onset hypothyroid brain. However, a single previous study indicates that postnatal hypothyroidism reduces *Shh* expression in the cerebellum, an effect suggested to contribute to the cerebellar morphological defects observed with postnatal hypothyroidism ([@B64]). In contrast to the extensive effects of adult-onset hyperthyroidism on expression of the Shh cascade, hypothyroidism in adulthood resulted in a spatially restricted and selective down-regulation of *Smo* expression within the DG. Adult-onset hypothyroidism is known to result in a neurogenic decline, through a reduced proliferation, survival, and neuronal differentiation of hippocampal progenitors ([@B12], [@B13], [@B15]). Shh is essential to the maintenance of the adult hippocampal stem cell niche and is known to modulate the proliferation, survival, and maintenance of adult progenitors ([@B29], [@B31]). We have previously demonstrated an effect of adult-onset hypothyroidism on hippocampal progenitors ([@B13]). Hypothyroidism resulted in a significant decrease in *Smo* mRNA levels selectively in the DG, raising the intriguing possibility that the neurogenic decline observed in hypothyroid animals may be mediated through a reduced responsivity to Shh signaling.

Subchronic T~3~ treatment also enhanced the number of β-galactosidase immunopositive cells within the neocortex of Shh^+/LacZ^ reporter mice, and colocalization experiments revealed that the expression of β-galactosidase was neuronal. We did not observe β-galactosidase expression in GFAP-positive astrocytes or NG2/RIP immunopositive oligodendrocytes in the neocortex. Recent studies suggest that thyroid hormone enhances oligodendrocytic progenitor recruitment and maturation to promote recovery in animal models of demyelination ([@B65]--[@B67]), and in some cases, it is accompanied by enhanced *Shh* expression ([@B65]). Further, under conditions of damage, reactive astrocytes within the cortex are reported to express Shh and induce oligodendrocytic progenitor proliferation ([@B68]). Shh administration into the neocortex of normal animals is also capable of recruiting premyelinating oligodendrocytic progenitors ([@B30], [@B69]). Our results indicate that T~3~ administration in normal animals induces neuronal Shh expression, and this may serve to recruit premyelinating oligodendrocytic progenitors even in the absence of overt damage.

The rapid effects of acute T~3~ administration on increased *Shh* expression *in vivo* and in cortical neurons *in vitro* suggest that the regulation of *Shh* expression by thyroid hormone in the brain may involve direct mechanisms. In contrast, the enhanced *Smo* and Ptc expression observed in adult-onset hyperthyroid animals is more likely to be a secondary consequence of changes in expression of the ligand. *In silico* analysis indicated the presence of putative TREs within upstream regulatory sequences of the *Shh* gene. Thyroid hormone mediated transcriptional regulation is associated with recruitment of coactivators and targeted histone acetylation changes in upstream regions of thyroid hormone-responsive genes ([@B70]). Previous studies from *Xenopus* demonstrate that T~3~ bound to TRs can recruit histone acetyl transferases to its target genes ([@B71], [@B72]), and the expression of thyroid hormone-responsive genes in *Xenopus* has also been shown to correlate with the acetylation status of their promoters ([@B73]). Our results demonstrate significant and rapid *in vivo* increases in global histone H3 and H4 acetylation both at the putative TRE sites within upstream regions of the *Shh* gene, as well as close to the transcriptional start site. Although evidence of rapid increases in histone acetylation provides partial support to the notion that *Shh* is directly transcriptionally regulated by thyroid hormone, future experiments are required to identify promoter elements that mediate thyroid hormone responsivity of the *Shh* gene. Further experiments to elucidate the role of select TR isoforms in thyroid hormone-mediated *Shh* transcriptional regulation, to address whether TRs exert their effects as homodimers or heterodimers with RXR, RAR, or TRAP, and to identify the TREs or retinoic acid response elements that mediate TH responsivity are required to unequivocally demonstrate that *Shh* is a direct thyroid hormone target gene.

To the best of our knowledge, we provide the first evidence that *Shh* expression is robustly regulated by thyroid hormone in the brain. Recent elegant studies have demonstrated an opposite regulation, showing that Shh signaling can modulate thyroid hormone activity in neuronal cells through the regulation of deiodinases 2 and 3. Shh has been reported to reduce thyroid hormone signaling through decreased deiodinase 2 and enhanced deiodinase 3 activity in astrocytes and neurons, respectively ([@B74]). This then evokes the tantalizing but speculative possibility of a negative feedback loop wherein thyroid hormone enhances neuronal Shh signaling and Shh serves to restrict thyroid hormone-mediated effects via deiodinase activity modulation. This raises the possibility of a powerful interplay between these two systems that may then play an important role in neurodevelopment, adult plasticity, and pathophysiology.

In conclusion, we find that the Shh pathway displays a striking and selective regulation within the adult brain and in distinct signaling areas of the early embryonic forebrain under conditions of adult-onset, and maternal, hyper- and hypothyroidism. We show that *Shh* expression is rapidly regulated both *in vivo* and *in vitro* in response to thyroid hormone, accompanied by significant epigenetic histone modifications within upstream regions of the *Shh* gene. Both thyroid hormone and Shh have been independently demonstrated to regulate diverse aspects of central nervous system development, including effects on proliferation and maturation, and to retain a profound influence on the adult brain, modulating recruitment, survival, and differentiation of neuronal and oligodendrocytic progenitors ([@B13], [@B14], [@B29], [@B31]). Our results suggest that specific developmental and plasticity associated actions of thyroid hormone may be mediated by its control of the Shh pathway and motivate future experiments to determine the mechanistic contribution of Shh to the effects of thyroid hormone in both the developing and mature nervous system.
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